A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Dr. Kevin Fahey Appointed to illumiSonics Board of Directors

February 10, 2021

illumiSonics Inc., is a medical tissue imaging company. Today they announced the appointment of Kevin Fahey, Ph.D., to the Board of Directors. The company has taken this action in anticipation of its growth and the commercial introduction of its proprietary Photo Acoustic Remote Sensing (PARS) tissue imaging platform.

Dr. Kevin Fahey brings new skills and will help strengthen the board of directors.

“Dr. Fahey brings commercial imaging domain expertise and industry-specific relationships to fully enable the power and unique capabilities of PARS as we fundamentally change the way the world looks at living tissue,” said Rocky Ganske CEO.

“PARS brings all of the valuable imaging of traditional photoacoustics, uniquely without the need for an interface. This capability opens several clinical applications not possible today with any other commercial imaging technology. We believe this creates a number of product and partnering opportunities for illumiSonics, and I am looking forward to participating,” said Dr. Fahey.

Dr. Fahey held executive positions at Xradia (acquired by ZEISS) and FEI (acquired by ThermoFisher), and at both large and small companies. In every case, he drove dramatic growth, creating new business lines and implementing integrated sales and marketing channels that drove rapid increases in sales. Dr. Fahey holds a Ph.D. in Materials Science and Engineering from Stanford University and a B.S. in Physics from the Massachusetts Institute of Technology.

illumiSonics’ proprietary PARS photoacoustic remote sensing technology is a revolution in optical imaging. Like traditional photoacoustic imaging, PARS measures optical absorption and is capable of providing functional and molecular imaging of anything that can absorb light. Traditional photoacoustic imaging has been constrained by the need to have contact with targeted tissues, the size of transducers and an inability to easily integrate with other optical imaging techniques. PARS is the first fully optical, non-contact photoacoustic imaging technology. This allows PARS to maintain all of the advantages of photoacoustic imaging while addressing its shortcomings, which provides incredible flexibility in how it can be deployed.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy